Based on two hallmarks of glioma, mutation of IDH1 and IDH2 genes, and codeletion of chromosome arms 1p/19q, glioma is primarily distinguished into five principle molecular subtypes. This evidence concerns the gene IDH1 and central nervous system cancer.